• Overview
  • Eligibility
  • More info
  • Locations

Comparative Effectiveness of Patient-Centered Strategies to Improve Pain Management and Opioid Safety for Veterans (NCT03026790)

Patient-Centered Outcomes Research Institute
Background and significance: Treatment with opioid pain medications (like hydrocodone and morphine) is common for severe pain, but studies show these medications may not always help and can cause serious problems. High daily doses of opioids can be especially unsafe. To help patients with chronic pain have better quality of life and avoid medication toxicity, health care teams need to manage pain while helping patients reduce opioid medication doses to safer levels.
  • Other: Medication management
    Individualized management of medications for pain
    • Other: Non-pharmacological pain management
      Individualized management of non-medication pain treatment approaches
      • Drug: Buprenorphine-Naloxone
        Option of using buprenorphine-naloxone to assist with opioid dose reduction or discontinuation
        Ages eligible for Study
        21 Years and older
        Genders eligible for Study
        All
        Accepts Healthy Volunteers
        No
        Inclusion Criteria:
        • Moderate or high-dose long-term opioid therapy (≥ 50 ME mg daily for at least 3 months) for chronic pain
        • Chronic pain of at least moderate severity (defined as pain that is present every or nearly every day for ≥ 6 months and with a score on the PEG 3-item pain measure of ≥ 5)
        Exclusion Criteria:
        • Dementia diagnosis or moderate-severe cognitive impairment, defined as ≥2 errors on six-item cognitive screener
        • Unstable or severe untreated psychiatric disorder, including severe untreated substance use disorder or active suicidal ideation
        • Unstable or end-stage medical disease that would interfere with participation, including cancer requiring active treatment and life expectancy < 12 months
        • Documentation of suspected controlled substance diversion
        • Inability to communicate by telephone
        Study aims: This study will test which of two pain treatment strategies is better for managing pain and helping patients improve safety of opioid medication. For patients on high opioid doses who want to reduce, this study will also test whether offering an extra option for tapering (buprenorphine-naloxone) helps them succeed. Finally, the study will examine patients' and clinicians' experiences with the interventions.

        Study description: The study will compare two treatment strategies among patients with pain who are taking long-term opioid pain medications prescribed by VA healthcare facilities across the country. Patients who wish to enter the study will be assigned by chance to telecare collaborative management (TCM) or integrated pain team (IPT). TCM involves a pharmacist and supervising physician working together to find the best medication options for each individual patient. In IPT, a team of clinicians focuses on non-medication pain management options, in addition to pain medication.

        All participants will be asked to stay in the study for 12 months. Patients for whom it would be unsafe to participate will not be invited to join. With either treatment strategy, TCM or IPT, participants will have individualized pain care tailored to their needs and preferences. Participants on high opioid medication doses who want to reduce their opioid medication dose will be assigned by chance to get either a regular step-wise taper or a choice between a regular taper or switching to a different medication (buprenorphine-naloxone).

        At the end of the study, the two treatment strategies will be compared to see which worked better to (1) decrease pain severity and (2) reduce opioid medication dose. Other outcomes important to patients will also be tracked. These include quality of life, sleep, fatigue, depression, anxiety, and side effects.

        1 locations

        United States (1)
        • Minneapolis VA Health Care System
          Not specified
          Minneapolis, Minnesota, United States, 55417
        Status:
        enrolling by invitation
        Type:
        Interventional
        Phase:
        Start:
        18 October, 2017
        Updated:
        26 October, 2017
        Participants:
        1400
        A girl giving information about available additional trials.

        FindMeCure helps you find, understand and join clinical trials from all over the world.

        There are more clinical trials for your condition!